Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2009 1
2010 1
2012 1
2014 1
2016 3
2017 3
2018 2
2019 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Tumor suppressors BTG1 and BTG2: Beyond growth control.
Yuniati L, Scheijen B, van der Meer LT, van Leeuwen FN. Yuniati L, et al. Among authors: van der meer lt. J Cell Physiol. 2019 May;234(5):5379-5389. doi: 10.1002/jcp.27407. Epub 2018 Oct 23. J Cell Physiol. 2019. PMID: 30350856 Free PMC article. Review.
Amino Acid Depletion Therapies: Starving Cancer Cells to Death.
Butler M, van der Meer LT, van Leeuwen FN. Butler M, et al. Among authors: van der meer lt. Trends Endocrinol Metab. 2021 Jun;32(6):367-381. doi: 10.1016/j.tem.2021.03.003. Epub 2021 Mar 29. Trends Endocrinol Metab. 2021. PMID: 33795176 Free article. Review.
Gfi1 and Gfi1b: key regulators of hematopoiesis.
van der Meer LT, Jansen JH, van der Reijden BA. van der Meer LT, et al. Leukemia. 2010 Nov;24(11):1834-43. doi: 10.1038/leu.2010.195. Epub 2010 Sep 23. Leukemia. 2010. PMID: 20861919 Review.
Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy.
Cox WPJ, Evander N, Van Ingen Schenau DS, Stoll GR, Anderson N, De Groot L, Grünewald KJT, Hagelaar R, Butler M, Kuiper RP, Van der Meer LT, Van Leeuwen FN. Cox WPJ, et al. Among authors: van der meer lt. Haematologica. 2023 Dec 21. doi: 10.3324/haematol.2023.284101. Online ahead of print. Haematologica. 2023. PMID: 38124624 Free article.
BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway.
Butler M, van Ingen Schenau DS, Yu J, Jenni S, Dobay MP, Hagelaar R, Vervoort BMT, Tee TM, Hoff FW, Meijerink JP, Kornblau SM, Bornhauser B, Bourquin JP, Kuiper RP, van der Meer LT, van Leeuwen FN. Butler M, et al. Among authors: van der meer lt. Blood. 2021 Dec 9;138(23):2383-2395. doi: 10.1182/blood.2021011787. Blood. 2021. PMID: 34280258 Free PMC article. Clinical Trial.
Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1.
Tijchon E, van Emst L, Yuniati L, van Ingen Schenau D, Gerritsen M, van der Meer LT, Williams O, Hoogerbrugge PM, Scheijen B, van Leeuwen FN. Tijchon E, et al. Among authors: van der meer lt. Exp Hematol. 2018 Apr;60:57-62.e3. doi: 10.1016/j.exphem.2018.01.006. Epub 2018 Feb 8. Exp Hematol. 2018. PMID: 29408281 Free article.
Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.
Yuniati L, van der Meer LT, Tijchon E, van Ingen Schenau D, van Emst L, Levers M, Palit SA, Rodenbach C, Poelmans G, Hoogerbrugge PM, Shan J, Kilberg MS, Scheijen B, van Leeuwen FN. Yuniati L, et al. Among authors: van der meer lt. Oncotarget. 2016 Jan 19;7(3):3128-43. doi: 10.18632/oncotarget.6519. Oncotarget. 2016. PMID: 26657730 Free PMC article.
16 results